Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.

Forbes contributors publish independent expert analyses and insights. I write about tax policy and how it affects business. A cornerstone of U.S. tax policy (and for many other countries) has been to ...

In this article, we will be taking a look at the 20 largest R&D companies in the world. If you want to go straight to the top five companies, you can go directly to see the 5 Largest R&D Companies in ...

Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...

Ben McClure is a seasoned venture finance advisor with 10+ years of experience helping CEOs secure early-stage investments. Get personalized, AI-powered answers built on 27+ years of trusted expertise ...

After nearly a decade as No. 1, Roche has finally been knocked off the top spot of our annual list of the biggest research and development budgets in pharma, sent spinning down the ladder by a ...

AkzoNobel, a global leader in paints and coatings, and Albert Invent, who is building the future of chemistry R&D, today announced an AI transformation partnership with AkzoNobel’s global R&D ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. David Kindness is a Certified Public ...

The pharmaceutical industry is grappling with diminishing R&D productivity. Our estimates suggest that the internal rate of return (IRR) on small-molecule R&D is now ∼7.5% (Fig. 1; see Supplementary ...